Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations

NCT07220330 is registered in ClinicalTrials.gov with Qbtech AB as lead sponsor.

NCT NCT07220330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07220330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations
Lead sponsor
Qbtech AB
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 15, 2025
Completion date
October 31, 2026
Enrollment
700 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder (adhd), healthy volunteer, no history of adhd